• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类乳头瘤病毒致癌蛋白:转化道路上靶向宿主通路的综述。

The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

机构信息

School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, West Yorkshire, LS2 9JT, UK.

Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, West Yorkshire, LS2 9JT, UK.

出版信息

J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001540. Epub 2021 Jan 11.

DOI:10.1099/jgv.0.001540
PMID:33427604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8148304/
Abstract

Persistent infection with high-risk human papillomaviruses (HR-HPVs) is the causal factor in over 99 % of cervical cancer cases, and a significant proportion of oropharyngeal and anogenital cancers. The key drivers of HPV-mediated transformation are the oncoproteins E5, E6 and E7. Together, they act to prolong cell-cycle progression, delay differentiation and inhibit apoptosis in the host keratinocyte cell in order to generate an environment permissive for viral replication. The oncoproteins also have key roles in mediating evasion of the host immune response, enabling infection to persist. Moreover, prolonged infection within the cellular environment established by the HR-HPV oncoproteins can lead to the acquisition of host genetic mutations, eventually culminating in transformation to malignancy. In this review, we outline the many ways in which the HR-HPV oncoproteins manipulate the host cellular environment, focusing on how these activities can contribute to carcinogenesis.

摘要

高危型人乳头瘤病毒(HR-HPV)的持续感染是超过 99%宫颈癌病例以及相当一部分口咽癌和肛门生殖器癌的致病因素。HPV 介导的转化的关键驱动因素是致癌蛋白 E5、E6 和 E7。它们共同作用以延长细胞周期进程、延迟宿主角质形成细胞的分化并抑制细胞凋亡,从而为病毒复制创造一个许可的环境。致癌蛋白还在介导逃避宿主免疫反应方面发挥关键作用,使感染持续存在。此外,在 HR-HPV 致癌蛋白所建立的细胞环境中持续感染可导致宿主遗传突变的获得,最终导致癌变。在这篇综述中,我们概述了 HR-HPV 致癌蛋白操纵宿主细胞环境的多种方式,重点介绍这些活动如何促进致癌作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/fbae1e87d096/jgv-102-1540-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/f7e4815a4cf7/jgv-102-1540-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/f79fb5574380/jgv-102-1540-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/7343a4b98f3b/jgv-102-1540-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/00e4d6f83c6d/jgv-102-1540-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/7601ecbce586/jgv-102-1540-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/fbae1e87d096/jgv-102-1540-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/f7e4815a4cf7/jgv-102-1540-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/f79fb5574380/jgv-102-1540-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/7343a4b98f3b/jgv-102-1540-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/00e4d6f83c6d/jgv-102-1540-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/7601ecbce586/jgv-102-1540-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c799/8148304/fbae1e87d096/jgv-102-1540-g006.jpg

相似文献

1
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.人类乳头瘤病毒致癌蛋白:转化道路上靶向宿主通路的综述。
J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001540. Epub 2021 Jan 11.
2
Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.人乳头瘤病毒相关癌症:最新知识更新。
Viruses. 2021 Nov 6;13(11):2234. doi: 10.3390/v13112234.
3
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.人乳头瘤病毒E6和E7癌蛋白作为肿瘤发生的危险因素。
J Biosci. 2009 Mar;34(1):113-23. doi: 10.1007/s12038-009-0013-7.
4
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.人乳头瘤病毒(HPV)癌蛋白对细胞凋亡的调控
Arch Virol. 2006 Dec;151(12):2321-35. doi: 10.1007/s00705-006-0821-0. Epub 2006 Jul 27.
5
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.高危型 HPV 对 JAK/STAT 信号通路的调控:HPV 相关恶性肿瘤的潜在治疗靶点。
Viruses. 2020 Sep 3;12(9):977. doi: 10.3390/v12090977.
6
Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.蛋白酶体降解 p130 促进高危型人乳头瘤病毒 16 和 18 E7 转染细胞的细胞周期失调和细胞分化障碍。
Mol Biol Rep. 2021 Jun;48(6):5121-5133. doi: 10.1007/s11033-021-06509-4. Epub 2021 Jun 24.
7
PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.PDZ 结构域蛋白 NHERF-2 是人类乳头瘤病毒 16(HPV-16)和 HPV-18 的一个新靶点。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.00663-19.
8
Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.人乳头瘤病毒 E6 和 E7 癌蛋白诱导细胞转化的分子机制。
Mutat Res Rev Mutat Res. 2017 Apr-Jun;772:23-35. doi: 10.1016/j.mrrev.2016.08.001. Epub 2016 Aug 5.
9
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.人乳头瘤病毒引起的细胞转化:比较高危和低危病毒得出的经验教训。
Virology. 2012 Mar 15;424(2):77-98. doi: 10.1016/j.virol.2011.12.018. Epub 2012 Jan 27.
10
The human papillomavirus family and its role in carcinogenesis.人乳头瘤病毒家族及其在致癌作用中的角色。
Semin Cancer Biol. 2014 Jun;26:13-21. doi: 10.1016/j.semcancer.2013.11.002. Epub 2013 Dec 4.

引用本文的文献

1
Harnessing the Power of Microbiota: How Do Key Species Aid in Clearing High-Risk Human Papilloma Virus Infection and Promoting the Regression of Cervical Dysplasia?利用微生物群的力量:关键物种如何帮助清除高危型人乳头瘤病毒感染并促进宫颈发育异常的消退?
Biology (Basel). 2025 Aug 19;14(8):1081. doi: 10.3390/biology14081081.
2
Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments.探索新型呋喃秋水仙碱衍生物作为HeLa细胞中有前景的JAK2抑制剂:结合对接、定量构效关系-机器学习、分子动力学模拟和实验
Comput Struct Biotechnol J. 2025 Aug 8;27:3625-3639. doi: 10.1016/j.csbj.2025.08.007. eCollection 2025.
3

本文引用的文献

1
E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.E6 介导的 JNK 激活促进 EGFR 信号通路,进而促进宫颈癌的增殖和病毒癌蛋白表达。
Cell Death Differ. 2021 May;28(5):1669-1687. doi: 10.1038/s41418-020-00693-9. Epub 2020 Dec 10.
2
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.高危型 HPV 对 JAK/STAT 信号通路的调控:HPV 相关恶性肿瘤的潜在治疗靶点。
Viruses. 2020 Sep 3;12(9):977. doi: 10.3390/v12090977.
3
The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation.
Emerging nanotherapeutics for HPV-associated cancers: current advances, challenges, and future directions.
用于人乳头瘤病毒相关癌症的新型纳米疗法:当前进展、挑战及未来方向
Discov Oncol. 2025 Aug 29;16(1):1653. doi: 10.1007/s12672-025-02439-w.
4
Genetic landscape of cancer: mechanisms, key genes, and therapeutic implications.癌症的遗传图谱:机制、关键基因及治疗意义。
Clin Transl Oncol. 2025 Aug 17. doi: 10.1007/s12094-025-04019-4.
5
Research on the regulatory effects and mechanisms of YES1 on apoptosis and autophagy in cervical cancer cells.YES1对宫颈癌细胞凋亡和自噬的调控作用及机制研究。
Discov Oncol. 2025 Aug 14;16(1):1555. doi: 10.1007/s12672-025-03425-y.
6
The Differential Expression of the JAK/STAT Pathway in Breast Cancer Cells Transfected with Human Papillomavirus Oncogenes.人乳头瘤病毒癌基因转染的乳腺癌细胞中JAK/STAT信号通路的差异表达
Viruses. 2025 Jun 23;17(7):880. doi: 10.3390/v17070880.
7
New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines.基于表达人乳头瘤病毒16型(HPV16)E6和E7的腺癌4T1细胞构建的新型小鼠模型,用于评估基于HPV16 E6/E7的治疗性和预防性疫苗的疗效。
Infect Agent Cancer. 2025 Jul 26;20(1):51. doi: 10.1186/s13027-025-00682-y.
8
The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study.人乳头瘤病毒基因型、肿瘤抑制因子和局部免疫反应对宫颈上皮内瘤变2-3级消退的预测影响:一项基于人群的前瞻性队列研究。
Int J Mol Sci. 2025 May 28;26(11):5205. doi: 10.3390/ijms26115205.
9
Human papillomavirus infection and screening strategies.人乳头瘤病毒感染与筛查策略
World J Clin Oncol. 2025 May 24;16(5):105055. doi: 10.5306/wjco.v16.i5.105055.
10
HPV16 E7 Enhances Cell Stemness via RTKN2-Mediated Activation of the NF-κB Pathway in Cervical Cancer.人乳头瘤病毒16型E7蛋白通过RTKN2介导的核因子κB信号通路激活增强宫颈癌的细胞干性
Biochem Genet. 2025 Jun 10. doi: 10.1007/s10528-025-11144-w.
人乳头瘤病毒 E6 蛋白将凋亡诱导因子(AIF)作为靶标进行降解。
Sci Rep. 2020 Aug 26;10(1):14195. doi: 10.1038/s41598-020-71134-3.
4
BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.BCCIPβ 通过与高危型 HPV 阳性头颈部鳞状细胞癌中的 E6 蛋白结合促进 p53 的泛素化。
Biochem Biophys Res Commun. 2020 Aug 27;529(3):685-691. doi: 10.1016/j.bbrc.2020.05.183. Epub 2020 Jul 18.
5
Promoter methylation of tumor suppressor genes induced by human papillomavirus in cervical cancer.人乳头瘤病毒诱导的宫颈癌中肿瘤抑制基因的启动子甲基化
Oncol Lett. 2020 Jul;20(1):955-961. doi: 10.3892/ol.2020.11625. Epub 2020 May 14.
6
MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.微小 RNA-18a 靶向 STK4/MST1 肿瘤抑制因子对于 HPV 阳性宫颈癌的转化是必要的。
PLoS Pathog. 2020 Jun 18;16(6):e1008624. doi: 10.1371/journal.ppat.1008624. eCollection 2020 Jun.
7
A masked initiation region in retinoblastoma protein regulates its proteasomal degradation.视网膜母细胞瘤蛋白中的一个掩蔽起始区域调节其蛋白酶体降解。
Nat Commun. 2020 Apr 24;11(1):2019. doi: 10.1038/s41467-020-16003-3.
8
The Role of Long Noncoding RNAs in Human Papillomavirus-associated Pathogenesis.长链非编码RNA在人乳头瘤病毒相关发病机制中的作用
Pathogens. 2020 Apr 15;9(4):289. doi: 10.3390/pathogens9040289.
9
Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.人乳头瘤病毒 E7 结合 Oct4 并调节其在 HPV 相关宫颈癌中的活性。
PLoS Pathog. 2020 Apr 16;16(4):e1008468. doi: 10.1371/journal.ppat.1008468. eCollection 2020 Apr.
10
The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer.微小RNA、长链非编码RNA和环状RNA在宫颈癌中的作用
Front Oncol. 2020 Feb 20;10:150. doi: 10.3389/fonc.2020.00150. eCollection 2020.